Your browser doesn't support javascript.
loading
Catalase-gold nanoaggregates manipulate the tumor microenvironment and enhance the effect of low-dose radiation therapy by reducing hypoxia.
Najafi, Alireza; Keykhaee, Maryam; Kazemi, Mohammad Hossein; Karimi, Mohammad Yahya; Khorramdelazad, Hossein; Aghamohamadi, Nazanin; Bolouri, Mohammad-Reza; Ghaffari-Nazari, Haniyeh; Mirsharif, Ensie Sadat; Karimi, Milad; Dehghan Manshadi, Hamid Reza; Mahdavi, Seied Rabi; Safari, Elahe; Jalali, Seyed Amir; Falak, Reza; Khoobi, Mehdi.
  • Najafi A; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Keykhaee M; Department of Pharmaceutical Biomaterials and Medical Biomaterial Research Center (MBRC), Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
  • Kazemi MH; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Karimi MY; Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.
  • Khorramdelazad H; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Aghamohamadi N; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Bolouri MR; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Ghaffari-Nazari H; Department of Immunology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Mirsharif ES; Immunoregulation Research Center, Shahed University, Tehran, Iran.
  • Karimi M; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Dehghan Manshadi HR; Department of Radiation Oncology, Hafte Tir Hospital, Iran University of Medical Sciences, Tehran, Iran.
  • Mahdavi SR; Radiation Biology Research Center& Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Safari E; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Jalali SA; Immunology Department, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Falak R; Immunology Research Center, Institute of Immunology and Infectious Diseases, Iran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Electronic address: falak.r@iums.ac.ir.
  • Khoobi M; Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: m-khoobi@tums.ac.ir.
Biomed Pharmacother ; 167: 115557, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37757491

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2023 Tipo del documento: Article